We could be close to a breakthrough in the search for a cure for the coronavirus. The most likely candidate: Gilead’s drug Remdesivir.
But Gilead wants to keep exclusive control over the drug’s patent.
And that’s bad news because Gilead is notorious for price gouging. It charges $1000 for a single pill of its hepatitis C drug!
But here’s the good news: right now all eyes are on Gilead -- the company is extremely sensitive to public pressure.
With your help, we’ll charter a plane to fly over Gilead’s headquarters and the whole of San Francisco to send a strong message to Gilead’s bosses: “Stop trying to make a profit from the coronavirus!”
And this won’t just get the attention of Gilead: it will be splashed all over the news, including all the big financial newspapers -- and Gilead’s bosses and shareholders will be freaked out by this negative publicity.
Can you chip in to make sure coronavirus drugs will be available to all?
More information
Gilead criticised over ‘orphan status’ for potential virus treatment
The Financial Times. 24 March 2020.
The Financial Times. 24 March 2020.
Hopes rise over experimental drug's effectiveness against coronavirus
The Guardian. 16 March 2020.
The Guardian. 16 March 2020.